GCK and Hypoglycemia: Results revealed that mice heterozygous for the inactivating mutation (Lys414Glu) displayed hyperglycemia, representing the phenotype of MODY2, while mice with the heterozygous activating mutation (Ala456Val) showed hypoglycemia, characteristic of GCK-HH [128].